{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:55:35Z","timestamp":1784580935390,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>In the era of antiretroviral therapy, lymphoma is the primary cause of cancer-related death among human immunodeficiency virus (HIV)-infected people and the most prevalent and aggressive non-Hodgkin lymphoma is diffuse large B cell lymphoma, which usually has an aggressive clinical course. CD5-positive diffuse large B cell lymphoma (DLBCL) is an insufficiently studied, relatively new entity, which accounts for 5% to 10% of the DLBCL population. The current study presents the clinicopathological features, diagnostic approach, and clinical outcomes of this HIV-related lymphoma and highlights the importance of the early diagnosis of CD5-positive DLBCL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present a case of a 30-year-old male patient, with a medical history of HIV-positive serology and antiviral treatment, presenting with diffuse abdominal pain and symptoms related to obstruction or perforation, followed by exploratory laparotomy and surgical resection of the small intestine with other areas of involvement. The surgical specimen was morphologically evaluated and immunohistochemical stained.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses and Interventions:<\/jats:title>\n            <jats:p>Histopathologic examination revealed a diffuse neoplastic proliferation of large B lymphocytes within the small intestine, lacking features of other defined types of large B cell lymphoma. The diagnosis of CD5-positive DLBCL subtype was made after immunostaining with twelve monoclonal antibodies (CD3, CD5, CD10, CD20, CD23, CD30, CD68, Cyclin D1, MUM1, Bcl2, Bcl6, and Ki-67). The expression profile of immunohistochemical markers (CD10, Bcl6, and MUM1) established the cell of origin of this case of DLBCL by using the Hans algorithm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The current report highlights the importance of early diagnosis of CD5-positive DLBCL because of its poor prognosis and calls attention to the critical importance to identify immunodeficiencies because doing so affects the types of treatments available. Although cell-of-origin is useful for predicting outcomes, the germinal center B cell like and activated-B cell like subtypes remain heterogeneous, with better, and worse prognostic subsets within each group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033083","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:02:37Z","timestamp":1677240157000},"page":"e33083","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-2585","authenticated-orcid":false,"given":"Miruna","family":"Cristian","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology - CEDMOG, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Clinical Pathology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Andrei","family":"Baz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Radiology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea Georgiana","family":"Stoica","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology - CEDMOG, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Hematology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"A\u0219chie","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology - CEDMOG, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Clinical Pathology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"},{"name":"Academy of Medical Sciences, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mihaela","family":"Ghinea","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Hematology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Deacu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Clinical Pathology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Bo\u0219oteanu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Clinical Pathology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Florentina","family":"Mitroi","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology - CEDMOG, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Clinical Pathology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Dobrin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology - CEDMOG, \u201cOvidius\u201d University of Constanta, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut Eduard","family":"Iordache","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Surgery, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Izabela","family":"B\u0103l\u021b\u0103tescu","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology - CEDMOG, \u201cOvidius\u201d University of Constanta, Constanta, Romania"},{"name":"Department of Clinical Pathology, \u201cSf. Apostol Andrei\u201d Emergency County Hospital, Constanta, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.hoc.2008.07.002","article-title":"Diffuse large B-cell lymphoma.","volume":"22","author":"Friedberg","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5114\/pjp.2016.63775","article-title":"A rare CD5-positive subgroup of diffuse large B-cell lymphoma \u2013 clinical, morphological, and immunophenotypic features in polish patients.","volume":"67","author":"Wo\u017anialis","year":"2016","journal-title":"Pol J Pathol"},{"key":"R5-20250805","first-page":"156","article-title":"CD5 expression is an adverse prognostic factor in diffuse large B-cell lymphoma.","volume":"41","author":"Zheng","year":"2012","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/annonc\/mdn392","article-title":"CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.","volume":"19","author":"Ennishi","year":"2008","journal-title":"Ann Oncol"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.37358\/RC.18.12.6812","article-title":"Synchronous association of two types of indolent lymphomas.","volume":"69","author":"A\u0219chie","year":"2018","journal-title":"Revista de chimie"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15403\/jgld-758","article-title":"Genetic antibiotic resistance of helicobacter pylori in South-Eastern Romania.","volume":"29","author":"Dumitru","year":"2020","journal-title":"J Gastrointetinal Liver Dis"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry.","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3109\/10428194.2013.780655","article-title":"Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors.","volume":"54","author":"Dierickx","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/0284186X.2013.844853","article-title":"A population-based study of 135 lymphomas after solid organ transplantation: the role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.","volume":"53","author":"Kinch","year":"2014","journal-title":"Acta Oncol"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/bjh.13621","article-title":"Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series.","volume":"171","author":"Montanari","year":"2015","journal-title":"Br J Haematol"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40164-017-0087-0","article-title":"Post-transplant lymphoproliferative disorder (PTLD): a single institutional experience of 141 patients.","volume":"6","author":"Bishnoi","year":"2017","journal-title":"Exp Hematol Oncol"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"e640e640","DOI":"10.1097\/HS9.0000000000000640","article-title":"Clinicopathologic characteristics, treatment, and outcomes of post-transplant lymphoproliferative disorders: a single-institution experience using 2017 WHO diagnostic criteria.","volume":"5","author":"King","year":"2021","journal-title":"Hemasphere"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jnci\/85.17.1382","article-title":"AIDS-related malignancies: the emerging epidemic.","volume":"85","author":"Levine","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1038\/sj.onc.1206815","article-title":"Pathologic aspects of AIDS malignancies.","volume":"22","author":"Bellan","year":"2003","journal-title":"Oncogene"},{"key":"R19-20250805","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.","volume":"105","author":"Gopal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ajh.23467","article-title":"Recent advances in de novo CD5+ diffuse large B cell lymphoma.","volume":"88","author":"Jain","year":"2013","journal-title":"Am J Hematol"},{"key":"R21-20250805","first-page":"e27201","article-title":"CD 5+ peripheral B cell lymphoma with transformation to CD 5+ diffuse large B cell lymphoma in the CNS: a case report treated with rituximab.","volume":"14","author":"Uczkowski","year":"2022","journal-title":"High Dose Methotrexate Cytarabine Intrathecal Methotrexate Cureus"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"e13046e13046","DOI":"10.1097\/MD.0000000000013046","article-title":"Prognostic impact of germinal center B-cell-like and non-germinal center B-cell-like subtypes of bone marrow involvement in patients with diffuse large B-cell lymphoma treated with R-CHOP.","volume":"97","author":"Cho","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R23-20250805","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"R24-20250805","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:11:39Z","timestamp":1754424699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033083","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}